Cannabis Bioscience International Holdings, Inc. (CBIH)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Oct 29, 2025, 2:46 PM EDT
CBIH Revenue
Cannabis Bioscience International Holdings had revenue of $24.20K in the quarter ending August 31, 2025, a decrease of -86.47%. This brings the company's revenue in the last twelve months to $148.34K, down -58.20% year-over-year. In the fiscal year ending May 31, 2025, Cannabis Bioscience International Holdings had annual revenue of $303.02K with 21.77% growth.
Revenue (ttm)
148.34K
Revenue Growth
-58.20%
P/S Ratio
35.27
Revenue / Employee
74.17K
Employees
2
Market Cap
5.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 303.02K | 54.18K | 21.77% |
| May 31, 2024 | 248.84K | -67.98K | -21.46% |
| May 31, 2023 | 316.83K | 101.85K | 47.37% |
| May 31, 2022 | 214.98K | -546.76K | -71.78% |
| May 31, 2021 | 761.74K | 471.50K | 162.46% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Cannabis Bioscience International Holdings News
- 16 days ago - CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery - Newsfile Corp
- 4 weeks ago - CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center - Newsfile Corp
- 1 year ago - CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy - Newsfile Corp
- 1 year ago - CBIH Strengthens Competitive Advantage with Rapid Expansion of Patent Filings - Newsfile Corp
- 1 year ago - CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications - GlobeNewsWire
- 1 year ago - CBIH Charts Path to Future Leadership in Cannabis Medicine - GlobeNewsWire
- 1 year ago - CBIH: Unleashing the Potential of Cannabis for Tomorrow's Medicine - Newsfile Corp
- 1 year ago - CBIH Submits Groundbreaking Cannabis Patents for Breast and Pancreatic Cancer Treatments - Newsfile Corp